And experimental study promises to revolutionize the lives of overweight people. Esteban Jodar is an endocrine doctor and has participated in a clinical trial with this same molecule in people with diabetes who are typically also obese. ensures that the results are spectacular and notorious 23 kilos on average.
“These are weight losses that had not been seen until now except with some other similar molecule or with surgery. These are new times for people with obesity,” says the expert.
The “magic” of this medicine is that reduces your appetite, increases satiety and delays gastric emptying. They also change the pattern of food preferences: people eat less salty snacks and are interested in healthier foods.
The doctor explains that right now this drug is pending approval by the European and Spanish regulatory authority. Specifically, it is about the drug to treat type 2 diabetes that usually occurs in obese people. This drug is under study for the treatment of obesity or overweight with comorbidities. What we call a body mass index greater than 27.
the drug reduces cardiovascular effects, not only helps reduce weight, controls diabetes and lowers blood pressure. “It’s a powerful weapon to treat obesity, metabolic syndrome and diabetes.”
–
